Add this result to my export selection BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 28 May 2012 These guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based... Read Summary Type: Guidance (Add filter)
Add this result to my export selection Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis Source: Database of Abstracts of Reviews of Effects - DARE (Remove filter) 02 September 2009 Bupropion, Fluvoxamine, Topiramate, Paroxetine, Nalmefene, Escitalopram, Lithium carbonate, valproate, Naltrexone, Nefazodone,... Type: Systematic Reviews (Add filter)
Add this result to my export selection Treatment of attention-deficit/hyperactivity disorder Source: Database of Abstracts of Reviews of Effects - DARE (Remove filter) 30 September 2001 biofeedback, efamol, haloperidol, hydroxyzine, imipramine, L-amphetamine, lithium carbonate, lethylphenidate, nicotine, nothing (e.g.... Type: Systematic Reviews (Add filter)